Survival in women with NSCLC: The role of reproductive history and hormone use

Journal of Thoracic Oncology

Volumn 9, Issue 3, 2014, Pages 355-361

  Katcoff, Hannah ^a   Wenzlaff, Angela S ^b   Schwartz, Ann G ^b  

^a UNIVERSITY OF MICHIGAN SCHOOL OF PUBLIC HEALTH   (United States)

^b KARMANOS CANCER INSTITUTE   (United States)

Author keywords

Hormone use; Non small cell lung cancer; Survival

Indexed keywords

ESTROGEN; PROGESTERONE;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; EDUCATIONAL STATUS; FEMALE; FOLLOW UP; HORMONAL THERAPY; HUMAN; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MIDDLE AGED; OVERALL SURVIVAL; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; RACE; REPRODUCTIVE HISTORY; SMOKING; YOUNG ADULT;

ADENOCARCINOMA; ADULT; AGED; CARCINOMA, LARGE CELL; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SQUAMOUS CELL; FEMALE; FOLLOW-UP STUDIES; HORMONE REPLACEMENT THERAPY; HUMANS; LUNG NEOPLASMS; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; REPRODUCTIVE HISTORY; SURVIVAL RATE;

EID: 84894585491     PISSN: 15560864     EISSN: 15561380     Source Type: Journal    
DOI: 10.1097/JTO.0000000000000077     Document Type: Article

References (35)

1. Cancer Facts & Figures 2012. Atlanta: American Cancer Society, 2012.
2. Howlader N, Noone AM, Krapcho M, et al. SEER Cancer Statistics Review, 1975-2010. Bethesda: National Cancer Institute. Available at: Http://seer.cancer.gov/csr/1975-2010/, based on November 2012 SEER data submission, posted to the SEER web site, April 2013.
3. Zang EA, Wynder EL. Differences in lung cancer risk between men and women: Examination of the evidence. J Natl Cancer Inst 1996;88:183-192.
4. Donington JS, Colson YL. Sex and gender differences in non-small cell lung cancer. Semin Thorac Cardiovasc Surg 2011;23:137-145.
5. Baik CS, Strauss GM, Speizer FE, Feskanich D. Reproductive factors, hormone use, and risk for lung cancer in postmenopausal women, the Nurses' Health Study. Cancer Epidemiol Biomarkers Prev 2010;19:2525-2533.
6. Brinton LA, Gierach GL, Andaya A, et al. Reproductive and hormonal factors and lung cancer risk in the NIH-AARP Diet and Health Study cohort. Cancer Epidemiol Biomarkers Prev 2011;20:900-911.
7. Brinton LA, Schwartz L, Spitz MR, Park Y, Hollenbeck AR, Gierach GL. Unopposed estrogen and estrogen plus progestin menopausal hormone therapy and lung cancer risk in the NIH-AARP Diet and Health Study Cohort. Cancer Causes Control 2012;23:487-496.
8. Chlebowski RT, Anderson GL, Manson JE, et al. Lung cancer among postmenopausal women treated with estrogen alone in the women's health initiative randomized trial. J Natl Cancer Inst 2010;102:1413-1421.
9. Chlebowski RT, Schwartz AG, Wakelee H, et al Women's Health Initiative Investigators. Oestrogen plus progestin and lung cancer in postmenopausal women (Women's Health Initiative trial): A post-hoc analysis of a randomised controlled trial. Lancet 2009;374:1243-1251.
10. Lim WY, Chen Y, Chuah KL, et al. Female reproductive factors, gene polymorphisms in the estrogen metabolism pathway, and risk of lung cancer in Chinese women. Am J Epidemiol 2012;175:492-503.
11. Pesatori AC, Carugno M, Consonni D, et al. Reproductive and hormonal factors and the risk of lung cancer: The EAGLE study. Int J Cancer 2013;132:2630-2639.
12. Schwartz AG, Wenzlaff AS, Prysak GM, et al. Reproductive factors, hormone use, estrogen receptor expression and risk of non small-cell lung cancer in women. J Clin Oncol 2007;25:5785-5792.
13. Weiss JM, Lacey JV Jr, Shu XO, et al. Menstrual and reproductive factors in association with lung cancer in female lifetime nonsmokers. Am J Epidemiol 2008;168:1319-1325.
14. Visbal AL, Williams BA, Nichols FC 3rd, et al. Gender differences in non-small-cell lung cancer survival: An analysis of 4,618 patients diagnosed between 1997 and 2002. Ann Thorac Surg 2004;78:209-215.
15. Alexiou C, Onyeaka CV, Beggs D, et al. Do women live longer following lung resection for carcinoma?. Eur J Cardiothorac Surg 2002;21:319-325.
16. Kligerman S, White C. Epidemiology of lung cancer in women: Risk factors, survival, and screening. AJR Am J Roentgenol 2011;196:287-295.
17. Moore KA, Mery CM, Jaklitsch MT, et al. Menopausal effects on presentation, treatment, and survival of women with non-small cell lung cancer. Ann Thorac Surg 2003;76:1789-1795.
18. Ganti AK, Sahmoun AE, Panwalkar AW, Tendulkar KK, Potti A. Hormone replacement therapy is associated with decreased survival in women with lung cancer. J Clin Oncol 2006;24:59-63.
19. Ayeni O, Robinson A. Hormone replacement therapy and outcomes for women with non-small-cell lung cancer: Can an association be confirmed?. Curr Oncol 2009;16:21-25.
20. Huang B, Carloss H, Wyatt SW, Riley E. Hormone replacement therapy and survival in lung cancer in postmenopausal women in a rural population. Cancer 2009;115:4167-4175.
21. Van Dyke AL, Cote ML, Wenzlaff AS, et al. Cytokine and cytokine receptor single-nucleotide polymorphisms predict risk for non-small cell lung cancer among women. Cancer Epidemiol Biomarkers Prev 2009;18:1829-1840.
22. Schwartz AG, Cote ML, Wenzlaff AS, et al. Chronic obstructive lung diseases and risk of non-small cell lung cancer in women. J Thorac Oncol 2009;4:291-299.
23. Cote ML, Yoo W, Wenzlaff AS, et al. Tobacco and estrogen metabolic polymorphisms and risk of non-small cell lung cancer in women. Carcinogenesis 2009;30:626-635.
24. Van Dyke AL, Cote ML, Prysak G, Claeys GB, Wenzlaff AS, Schwartz AG. Regular adult aspirin use decreases the risk of non-small cell lung cancer among women. Cancer Epidemiol Biomarkers Prev 2008;17:148-157.
25. Skuladottir H, Olsen JH. Can reproductive pattern explain better survival of women with lung cancer?. Acta Oncol 2006;45:47-53.
26. Cheng MH, Tsai SS, Chen CC, et al. Parity and risk of death from lung cancer among a cohort of premenopausal parous women in Taiwan. J Epidemiol 2012;22:364-369.
27. Lindberg BS, Johansson ED, Nilsson BA. Plasma levels of nonconjugated oestrone, oestradiol-17beta and oestriol during uncomplicated pregnancy. Acta Obstet Gynecol Scand Suppl 1974;32:21-36.
28. Chakraborty S, Ganti AK, Marr A, Batra SK. Lung cancer in women: Role of estrogens. Expert Rev Respir Med 2010;4:509-518.
29. Ettinger B, Friedman GD, Bush T, Quesenberry Jr. CP. Reduced mortality associated with long-Term postmenopausal estrogen therapy. Obstet Gynecol 1996;87:6-12.
30. Siegfried JM, Hershberger PA, Stabile LP. Estrogen receptor signaling in lung cancer. Semin Oncol 2009;36:524-531.
31. Kazmi N, Márquez-Garbán DC, Aivazyan L, et al. The role of estrogen, progesterone and aromatase in human non-small-cell lung cancer. Lung Cancer Manag 2012;1:259-272.
32. Mah V, Seligson DB, Li A, et al. Aromatase expression predicts survival in women with early-stage non small cell lung cancer. Cancer Res 2007;67:10484-10490.
33. Ishibashi H, Suzuki T, Suzuki S, et al. Progesterone receptor in non-small cell lung cancer-A potent prognostic factor and possible target for endocrine therapy. Cancer Res 2005;65:6450-6458.
34. Stabile LP, Dacic S, Land SR, et al. Combined analysis of estrogen receptor beta-1 and progesterone receptor expression identifies lung cancer patients with poor outcome. Clin Cancer Res 2011;17:154-164.
35. Schwartz AG, Prysak GM, Murphy V, et al. Nuclear estrogen receptor beta in lung cancer: Expression and survival differences by sex. Clin Cancer Res 2005;11:7280-7287.